Back to Journals » OncoTargets and Therapy » Volume 16

Case report

Sustained Clinical Response to 4th-Line Therapy with Selpercatinib in RET Fusion-Positive Combined Small Cell Lung Cancer

       
Total article views   HTML views PDF downloads Totals
2,323 Dovepress* 2,199+ 62 2,261
PubMed Central* 124 39 163
Totals 2,323 101 2,424
*Since 29 November 2023

View citations on PubMed Central and Google Scholar